Clinical trial
The Clinical Significance of Surveillance of Lymphocyte and Immunocyte Subsets in Peripheral Blood of Esophageal Squamous Cell Carcinoma Patients With Neoadjuvant Chemoradiotherapy Combine Surgery or Surgery Alone (pLINE）.
NCT04440332 is registered in ClinicalTrials.gov with Sichuan Cancer Hospital and Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Clinical Significance of Surveillance of Lymphocyte and Immunocyte Subsets in Peripheral Blood of Esophageal Squamous Cell Carcinoma Patients With Neoadjuvant Chemoradiotherapy Combine Surgery or Surgery Alone (pLINE）.
- Lead sponsor
- Sichuan Cancer Hospital and Research Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- December 31, 2022
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal squamous cell carcinoma, neoadjuvant therapy, surgery